Saturna Capital Corp Takes Position in GE HealthCare Technologies Inc. $GEHC

Saturna Capital Corp acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 8,655 shares of the company’s stock, valued at approximately $616,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Laurel Wealth Advisors LLC purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at about $26,000. Optima Capital LLC bought a new stake in GE HealthCare Technologies during the fourth quarter worth about $27,000. Godfrey Financial Associates Inc. purchased a new position in shares of GE HealthCare Technologies in the 4th quarter worth about $27,000. Montag A & Associates Inc. boosted its holdings in shares of GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 262 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at GE HealthCare Technologies

In related news, Director Watkin Phoebe L. Yang bought 1,000 shares of the company’s stock in a transaction dated Friday, May 8th. The stock was purchased at an average cost of $63.01 per share, with a total value of $63,010.00. Following the transaction, the director owned 13,702 shares in the company, valued at approximately $863,363.02. This trade represents a 7.87% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO James Saccaro bought 3,310 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were bought at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the purchase, the chief financial officer directly owned 87,471 shares in the company, valued at approximately $5,300,742.60. This represents a 3.93% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders bought 21,847 shares of company stock worth $1,361,355. 0.36% of the stock is owned by corporate insiders.

GE HealthCare Technologies Trading Down 1.3%

GEHC opened at $62.04 on Wednesday. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The business has a 50 day simple moving average of $63.66 and a two-hundred day simple moving average of $71.60. The firm has a market capitalization of $28.22 billion, a price-to-earnings ratio of 14.84, a PEG ratio of 1.71 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same period last year, the firm posted $1.01 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a $0.035 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.35%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the company. Barclays decreased their price objective on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th. Wells Fargo & Company reduced their price target on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research report on Thursday, April 30th. The Goldman Sachs Group reissued a “neutral” rating on shares of GE HealthCare Technologies in a research note on Monday, June 8th. Weiss Ratings lowered shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 15th. Finally, Argus cut their price objective on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Tuesday, May 19th. Ten investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $76.41.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.